Akili Grabs CE Mark for Children’s Digital ADHD Treatment Post author:Sam Post published:June 22, 2020 Post category:Devices & Diagnostics Letter The FDA last week cleared EndeavorRx for marketing in the U.S. Source: Devices & Diagnostics Letter You Might Also Like FDA Warns of Possible Failure of EpiPen Injectors March 24, 2020 J&J to Start Largest Phase 3 Vaccine Trial Yet in September August 20, 2020 Soligenix Nabs Fast Track Status for RiVax February 24, 2020
